LMTK2 and prostate cancer: In contrast, knock down of LMTK2 in HEK293 cells expressing AR (analogous to prostate cancer cells) enhanced androgen-dependent activation of reporter gene by three fold in comparison to parental cells and by six fold in comparison to cells overexpressing LMTK2 (Fig. 5C).